SCHEMBL20260798

SCHEMBL20260798

CC(C)N1CC2(CCNCC2)c2cc(Br)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.35
BACE1 P56817 4/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
HTR2A P28223 1/20 0.33
HIF1A Q16665 1/20 0.33
SIGMAR1 Q99720 3/20 0.32
SLC18A3 Q16572 2/20 0.32
GAA P10253 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
HTR7 P34969 1/20 0.31
TMEM97 Q5BJF2 1/20 0.31
KDM1A O60341 1/20 0.31
PNMT P11086 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17771735 0.82 SIGMAR1 (0.42) AKT1BACE1HTR2CHTR2BSIGMAR1
SCHEMBL17452502 0.80 AKT1 (0.46) AKT1CYP1A2CYP3A4CYP2D6SIGMAR1
SCHEMBL12847640 0.78 HSD17B3 (0.37) AKT1HTR2CHTR2BCYP1A2CYP3A4
SCHEMBL12790810 0.78 AKT1 (0.33) AKT1BACE1HTR2CHTR2BHTR2A
SCHEMBL20242250 0.76 ALK (0.32) BACE1SIGMAR1SLC18A3
SCHEMBL22938493 0.76 RARA (0.38) BACE1HTR2CHTR2BCYP1A2CYP3A4
SCHEMBL12084831 0.76 NOTUM (0.58) AKT1GAAL3MBTL1
SCHEMBL1822246 0.74 SLC18A3 (0.42) AKT1BACE1HTR2CHTR2BCYP1A2
SCHEMBL24245042 0.72 PIK3CA (0.42) BACE1HTR2CHTR2BCYP1A2CYP3A4
SCHEMBL10311204 0.72 ALDH1A1 (0.37) AKT1CYP3A4HTR7KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018106646-A1 AMINOTRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-06-14 WO disclosed